+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gene Delivery Technologies Market Share, Size, Trends, Industry Analysis Report, By Mode; By Application; By Method; By Regions; Segment Forecast, 2021 -2028

  • ID: 5321999
  • Report
  • April 2021
  • Region: Global
  • 127 pages
  • Polaris Market Research
The global gene delivery technologies market size is expected to reach USD 7.86 billion by 2028 according to a new study. The report “Gene Delivery Technologies Market Share, Size, Trends, Industry Analysis Report, By Mode (Biological [Adenovirus, Retrovirus, AAV, Lentivirus, Other Viruses, Non-viral], Chemical, Physical); By Application (Gene Therapy, Cell Therapy, Vaccines, Research); By Method; By Regions; Segment Forecast, 2021 -2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

In 2020, the gene therapy market segment accounted for the largest share. Worldwide acceptance of gene therapies and subsequent rise in clinical research activities have boosted the segment’s market growth. Moreover, rising approvals for gene therapy products and services also accelerated the gene delivery technologies market growth prospects.

The vaccine market segment is projected to witness a lucrative growth rate over the gene delivery technologies study period. This is primarily due to the ability of such vaccines for different treatment approaches for both preventive and therapeutic areas. They have the potential to activate potent humoral responses. This has boosted the demand for gene editing tools for vaccine development.

The gene delivery technologies market segment is anticipated to benefit from a sudden rise in COVID-19 cases. As of August 2020, more than 25 research groups have been working for vector-based vaccines to contain COVID-19 infection. Similarly, approximately 20 research teams are exploring approaches to develop nucleic acid vaccines.

Market participants in gene delivery technologies industry include Horizon Discovery Group Co., QIAGEN, Oxford Biomedica, SignaGen Laboratories, Hoffmann-La Roche AG, Vectalys, Sirion-Biotech GmbH, Takara Bio Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., OriGene Technologies, Inc., System Biosciences, Promega Corporation, and Catalent Inc.

The market players operating in the gene delivery technologies industry are focusing on mergers and acquisitions to stay competitive in the market. In line with this, in May 2020, Merck, completed the acquisition of Themis, an immune-modulation therapy to expand its vaccine development program for the surging COVID-19 numbers. Similarly, earlier, in May 2019, already acquired Brammer Bio, a US-based company engaged in the development of viral vectors to be used in gene therapies.

The publisher segmented the gene delivery technologies market report on the basis of mode, application, method, and region:

Gene Delivery Technologies, Mode Outlook
  • Biological
  • Adenovirus
  • Retrovirus
  • AAV
  • Lentivirus
  • Other viruses
  • Non-viral
  • Chemical
  • Physical
Gene Delivery Technologies, Application Outlook
  • Gene Therapy
  • Cell Therapy
  • Vaccines
  • Research
Gene Delivery Technologies, Method Outlook
  • Ex vivo
  • In vivo
  • In vitro
Gene Delivery Technologies, by Regional Outlook
  • North America
  • US
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Central & South America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Note: Product cover images may vary from those shown
1. Introduction
1.1. Report Description
1.2. Stakeholders

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.2. Data Sources

4. Gene Delivery Technologies Market Insights
4.1. Gene Delivery Technologies – Industry snapshot
4.2. Gene Delivery Technologies Market Dynamics
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Gene Delivery Technologies Market Industry trends

5. Gene Delivery Technologies Market Assessment by Mode
5.1. Key Findings
5.2. Introduction
5.3. Biological
5.4. Chemical
5.5. Physical

6. Global Gene Delivery Technologies Market, by Application
6.1. Key Findings
6.2. Introduction
6.3. Gene Therapy
6.4. Cell Therapy
6.5. Vaccines
6.6. Research

7. Gene Delivery Technologies Market Assessment by Method
7.1. Key Findings
7.2. Introduction
7.3. Ex vivo
7.4. In vivo
7.5. In vitro

8. Gene Delivery Technologies Market Assessment by Geography
8.1. Key findings
8.2. Introduction
8.3. Gene Delivery Technologies Market – North America
8.4. Gene Delivery Technologies Market – Europe
8.5. Gene Delivery Technologies Market – Asia-Pacific
8.6. Gene Delivery Technologies Market – Middle East & Africa
8.7. Gene Delivery Technologies Market – Latin America

9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles
10.1. Thermo Fisher Scientific, Inc.
10.2. Horizon Discovery Group Co.
10.3. OriGene Technologies, Inc.
10.4. Oxford Biomedica
10.5. SignaGen Laboratories
10.6. Takara Bio Inc.
10.7. System Biosciences llc
10.8. Promega Corporation
10.9. F. Hoffmann - La Roche AG
10.10. QIAGEN
10.11. Vectalys
10.12. Bio - Rad Laboratories, Inc.
10.13. Catalent Inc.
10.14. Agilent Technologies
10.15. Sirion - Biotech GmbH

List of Tables
Table 1 Global Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 2 Global Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 3 Global Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 4 Gene Delivery Technologies Market Assessment, By Geography, 2016 – 2028 (USD Million)
Table 5 North America: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 6 North America: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 7 North America: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 8 U.S.: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 9 U.S.: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 10 U.S.: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 11 Canada: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 12 Canada: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 13 Canada: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 14 Europe: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 15 Europe: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 16 Europe: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 17 UK: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 18 UK: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 19 UK: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 20 France: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 21 France: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 22 France: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 23 Germany: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 24 Germany: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 25 Germany: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 26 Italy: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 27 Italy: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 28 Italy: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 29 Spain: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 30 Spain: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 31 Spain: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 32 Netherlands: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 33 Netherlands: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 34 Netherlands: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 35 Austria: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 36 Austria: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 37 Austria: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 38 Asia Pacific: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 39 Asia Pacific: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 40 Asia Pacific: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 41 China: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 42 China: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 43 China: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 44 India: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 45 India: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 46 India: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 47 Malaysia: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 48 Malaysia: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 49 Malaysia: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 50 Japan: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 51 Japan: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 52 Japan: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 53 Indonesia: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 54 Indonesia: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 55 Indonesia: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 56 South Korea: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 57 South Korea: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 58 South Korea: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 59 Middle East & Africa: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 60 Middle East & Africa: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 61 Middle East & Africa: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 62 Saudi Arabia: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 63 Saudi Arabia: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 64 Saudi Arabia: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 65 UAE: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 66 UAE: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 67 UAE: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 68 Israel: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 69 Israel: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 70 Israel: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 71 South Africa: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 72 South Africa: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 73 South Africa: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 74 Latin America: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 75 Latin America: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 76 Latin America: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 77 Mexico: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 78 Mexico: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 79 Mexico: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 80 Brazil: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 81 Brazil: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 82 Brazil: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)
Table 83 Argentina: Gene Delivery Technologies Market, By Mode, 2016 – 2028 (USD Million)
Table 84 Argentina: Gene Delivery Technologies Market, By Application, 2016 – 2028 (USD Million)
Table 85 Argentina: Gene Delivery Technologies Market, By Method, 2016 – 2028 (USD Million)

List of Figures
Figure 1. Market Highlights (2020, Revenue)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top Down & Bottom Up Approach
Figure 4. Market by Geography
Figure 6. Porter’s Five Forces
Figure 7. Market by Mode
Figure 8. Global Gene Delivery Technologies Market, By Mode, 2020 & 2028 (USD Million)
Figure 9. Market by Application
Figure 10. Global Gene Delivery Technologies Market, By Application, 2020 & 2028 (USD Million)
Figure 11. Market by Method
Figure 12. Global Gene Delivery Technologies Market, By Method, 2020 & 2028 (USD Million)
Figure 13. Gene Delivery Technologies Market Assessment, By Geography, 2016 – 2028 (USD Million)
Figure 14. Strategic Analysis – Gene Delivery Technologies Market
Note: Product cover images may vary from those shown
Horizon Discovery Group Co., QIAGEN, Oxford Biomedica, SignaGen Laboratories, Hoffmann-La Roche AG, Vectalys, Sirion-Biotech GmbH, Takara Bio Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., OriGene Technologies, Inc., System Biosciences, Promega Corporation, and Catalent Inc.
Note: Product cover images may vary from those shown
Adroll
adroll